Leading Global Cancer Center Expands Use of Abridge AI Platform for Oncology Clinical Documentation

🩺 Announcement: The Abridge platform for clinical conversations will now be implemented at Memorial Sloan Kettering Cancer Center—one of the premier cancer centers in the world—following a viability pilot conducted through the MSK Innovation Hub program.

MSK clinicians found that Abridge accurately captured the complexity of terminology in oncological specialties—and enhanced care for MSK’s multi-language patient population. 

“Both clinicians and patients who consented to evaluate Abridge at MSK gave positive feedback about the quality of its performance and the impact on their experience. We are looking forward to expanding its use at MSK, bringing advanced digital tools to the bedside that help our clinicians focus on the care of their patients, not clicks in the EHR.” —Peter Stetson, MD, MSK’s Chief Health Informatics Officer. 

Read more about the partnership here.